公司介绍：卓正医疗成立于2012年，是中国领先的私立中高端综合医疗服务机构，专注服务中高端医疗 市场，以大众富裕人群为核心目标客户。公司通过集中化、标准化及数字化管理系统，构建了覆盖中国 经济发达城市的服务网络，截至最后实际可行日期，在中国拥有19家医疗服务机构（含17家诊所及2家 医院），并在新加坡运营4家全科诊所、马来西亚运营1家全科诊所。采用家庭医疗模式，整合实体与线 上服务，提供儿科、齿科、眼科、皮肤科、耳鼻喉及外科、妇科、内科等多专科服务，强调循证医学原 则与全人医疗理念，通过跨科室协作满足患者家庭全生命周期健康需求，建立了实体与线上一体化的医 疗服务体系。 点击查看公告原文>> 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 来源：新 ...

Core Viewpoint - The resignation of Chen Dongfeng, the General Manager of Lianchi Hospital Group, raises concerns about the company's future strategic planning and development amidst ongoing challenges in its listing process [7]. Group 1: Resignation of Key Executive - Chen Dongfeng has resigned from his positions as a director, member of the remuneration and assessment committee, and General Manager of Lianchi Hospital, effective immediately due to personal reasons [2]. - Chen Dongfeng's annual salary was 1.07 million yuan, significantly higher than that of the Chairman and other executives [2]. Group 2: Company Performance - Lianchi Hospital's revenue has shown steady growth, increasing from 228 million yuan in 2018 to 419 million yuan in 2024, with a 19.95% year-on-year growth in the first half of 2025, achieving 233 million yuan [4]. Group 3: Listing Attempts - The company has faced multiple setbacks in its listing journey, initially attempting to list on the New Third Board in 2015, then shifting to the Growth Enterprise Market in 2021, and later to the Beijing Stock Exchange in 2022 [5]. - As of July 2024, Lianchi Hospital announced plans to apply for listing on the Beijing Stock Exchange, intending to raise funds for the relocation of the Zibo Lianchi Orthopedic Hospital and for information technology upgrades [5]. - However, the company has not yet engaged a counseling agency or signed a counseling agreement, indicating significant uncertainty in its listing process [5][6].